You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV integrase Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

Recruiting
  • HIV I Infection
  • +2 more
  • Doravirine 100 Mg
  • Los Angeles, California
  • +1 more
Nov 1, 2022

Gut Microbiota, PGx and INSTIs Response

Recruiting
  • HIV Infections
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 16, 2023

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)

Recruiting
  • HIV-1-infection
  • Multi-Antiviral Resistance
  • REGISTER CREATION
  • Milan, MI, Italy
    Ospedale San Raffaele
Dec 22, 2021

Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

Enrolling by invitation
  • Hiv
  • Weight Gain
  • Toronto, Ontario, Canada
    University Health Network
May 17, 2022

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

Recruiting
  • HIV Infections
  • Doravirine 100 Mg
  • +5 more
  • Birmingham, Alabama
  • +22 more
Feb 22, 2022

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)

Not yet recruiting
  • Hiv
  • plasma inflammatory markers
  • CD4/CD8 ratio
  • Nice, France
    CHU Nice
Jan 16, 2023

HIV Reservoir, Inflammation and Microbiota Footprint of PLWH

Recruiting
  • HIV Infections
  • Stool sampling
  • Blood plasma collection
  • Marseille, France
    Hôpital Européen Marseille
Jul 26, 2022

Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)

Terminated
  • Human Immunodeficiency Virus
  • Oakland Park, Florida
    Midland Research Group, Inc
Dec 3, 2021

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

Not yet recruiting
  • Tuberculous Meningitis
  • HIV I Infection
  • Adalimumab Injection
  • Rio De Janeiro, Brazil
  • +2 more
Jan 31, 2023

HIV-1 Infection Trial in France (Samplings)

Recruiting
  • HIV-1 Infection
  • Samplings
  • Clamart, France
  • +6 more
Jan 4, 2022

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

Assess the ART Impact on the Brain Outcomes. The ARBRE Study

Completed
Has Results
  • HIV-1 Infection
  • Cognitive Impairment
    • (no location specified)
    May 15, 2020

    HIV Trial in United States (Ritonavir, Saquinavir, Methadone HCl)

    Completed
    • HIV Infections
    • San Francisco, California
    • +6 more
    Oct 27, 2021

    NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

    Not yet recruiting
    • Nonalcoholic Fatty Liver Disease
    • +3 more
      • (no location specified)
      Apr 18, 2022

      PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

      Completed
      • Infection, Human Immunodeficiency Virus I
      • DTG based ARV regimen with ABC
      • +4 more
      • (no location specified)
      Feb 5, 2020

      HIV-infected Patient Kidney Transplant Recipient Trial (Biktarvy Tab)

      Not yet recruiting
      • HIV-infected Patient Kidney Transplant Recipient
      • Biktarvy Tab
      • (no location specified)
      Aug 3, 2021

      Intensive Viral Dynamics Substudy of A5248

      Completed
      • HIV Infections
      • Treatment Naive
        • Aurora, Colorado
        • +5 more
        Oct 28, 2021

        HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

        Completed
        Has Results
        • HIV Infections
        • Placebo for maraviroc (MVC)
        • +3 more
        • Los Angeles, California
        • +29 more
        Apr 20, 2022